cord blood stem cell
Showing 1 - 25 of >10,000
Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Recombinant Interleukin-7
-
Houston, TexasM D Anderson Cancer Center
Jan 26, 2023
Cerebral Palsy Trial in Augusta (Cord Blood Infusion, Intravenous Sham)
Withdrawn
- Cerebral Palsy
- Cord Blood Infusion
- Intravenous Sham
-
Augusta, GeorgiaAugusta University
Oct 6, 2022
MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)
Recruiting
- Myelodysplastic Syndromes
- +2 more
- unrelated umbilical cord blood
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Oct 16, 2022
Neonatal Hypoxic-ischaemic Encephalopathy Trial in Marseille (autologous cord blood stem cell)
Recruiting
- Neonatal Hypoxic-ischaemic Encephalopathy
- autologous cord blood stem cell
-
Marseille, FranceAssistance Publique Hopitaux de Marseille
Aug 12, 2022
Bone Marrow Transplant, Stem Cell Transplant Trial in Aurora (Zoster Vaccine Recombinant)
Not yet recruiting
- Bone Marrow Transplant
- Stem Cell Transplant
- Zoster Vaccine Recombinant
-
Aurora, ColoradoUniversity of Colorado Hospital
Mar 17, 2023
Myeloid Hematological Malignancies Trial in Houston (Busulfan, Cyclophosphamide, Fludarabine)
Completed
- Myeloid Hematological Malignancies
- Busulfan
- +3 more
-
Houston, TexasTexas Children's Hospital
May 13, 2022
Hypoplastic Left Heart Syndrome, Heart Defects, Congenital, Pediatric Disorder Trial in Melbourne (Autologous Human Placental
Completed
- Hypoplastic Left Heart Syndrome
- +2 more
- Autologous Human Placental Cord Blood Mononuclear Cells
-
Melbourne, Victoria, AustraliaRoyal Children's Hospital
Jul 19, 2022
Congenital Pediatric Disorders Trial in Houston (Busulfan, Cytoxan, Fludarabine)
Active, not recruiting
- Congenital Pediatric Disorders
- Busulfan
- +3 more
-
Houston, TexasTexas Children's Hospital
Feb 4, 2022
Acute Leukemia Trial in Tianjin (Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation,
Recruiting
- Acute Leukemia
- Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation
- haploidentical hematopoietic stem cell transplantation
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Aug 9, 2022
Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)
Recruiting
- Leukemia
- +2 more
- applying of FLU+CY post-HSCT
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Nov 23, 2023
Cerebral Palsy Trial in Houston (Umbilical Cord Blood Stem Cells, Saline Infusion (Placebo), Bone Marrow Stem Cells)
Completed
- Cerebral Palsy
- umbilical cord blood (hUCB) cells
- +2 more
-
Houston, TexasUTHealth, Medical School, Dept. of Pediatric Surgery
Oct 27, 2022
Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation
Completed
- Leukemia
- +2 more
- CliniMACS Fractionation system (Arm A)
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 12, 2022
Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)
Active, not recruiting
- Plasma Cell Leukemia
- Plasma Cell Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Malignant Hematological Diseases
- Umbilical Cord Blood Transplantation
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow university
Jul 3, 2023
Sickle Cell Disease, Umbilical Cord Blood, Hematopoietic Cell Proliferation Trial in Palo Alto, San Francisco (ECT-001-CB
Withdrawn
- Sickle Cell Disease
- +2 more
- ECT-001-CB (UM171-Expanded Cord Blood Transplant)
-
Palo Alto, California
- +1 more
Jun 29, 2022
Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood
Recruiting
- Hematopoietic Malignancy
- +2 more
- Umbilical Cord Blood Transplantation
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow university
Nov 6, 2023
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States
Completed
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- +5 more
- Hematopoietic Umbilical Cord Blood Stem Cell Transplantation
- GVHD prophylaxis
-
Duarte, California
- +15 more
Nov 2, 2021
Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,
Recruiting
- Acute Erythroid Leukemia
- +10 more
- Fludarabine
- +5 more
-
San Francisco, California
- +5 more
Nov 1, 2022
Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Adrenoleukodystrophy Trial in Denver, Valhalla, Salt Lake City (Human
Completed
- Mucopolysaccharidosis I
- +15 more
- Human Placental Derived Stem Cell
-
Denver, Colorado
- +2 more
Oct 24, 2022
Stem Cell Transplantation Trial in Durham (Thymic Transplantation for Recipients of UCB transplant)
Terminated
- Stem Cell Transplantation
- Thymic Transplantation for Recipients of UCB transplant
-
Durham, North CarolinaDuke University Health System
Mar 21, 2022
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Seattle
Recruiting
- Acute Biphenotypic Leukemia
- +5 more
- Dilanubicel
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
May 11, 2022
Ischemic Stroke Trial in Hanoi (UC-MSC infusion via intravenous route, UC-MSC infusion via intrathecal route, standard stroke
Recruiting
- Ischemic Stroke
- UC-MSC infusion via intravenous route
- +2 more
-
Hanoi, VietnamVinmec Research Institute of Stem Cell and Gene Technology
Mar 22, 2022
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023
Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA), Severe Aplastic Anemia (SAA) Trial run by the NHLBI (Umbilical Cord
Completed
- Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)
- Severe Aplastic Anemia (SAA)
- Umbilical Cord Blood
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 16, 2021